Arnica Montana and Bromelain in Rhinoplasty
Status: | Not yet recruiting |
---|---|
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 3/28/2019 |
Start Date: | April 2019 |
End Date: | February 2020 |
Contact: | Jacqueline Wulu, MD |
Email: | jacqueline.wulu@bmc.org |
Phone: | 617-414-2305 |
Effects of Arnica Montana and Bromelain in Rhinoplasty
The purpose of this study is to assess the perioperative use of Arnica Montana and the
combined use of Arnica Montana and Bromelain in aiding the body's wound healing functions
during the postoperative period after rhinoplasty. The secondary objective of the study is to
determine if there is a reduction in postoperative edema when Arnica Montana and Bromelain
are combined. Another secondary objective is to demonstrate increased patient satisfaction
with the use of Arnica Montana and the combination Arnica Montana and Bromelain.
combined use of Arnica Montana and Bromelain in aiding the body's wound healing functions
during the postoperative period after rhinoplasty. The secondary objective of the study is to
determine if there is a reduction in postoperative edema when Arnica Montana and Bromelain
are combined. Another secondary objective is to demonstrate increased patient satisfaction
with the use of Arnica Montana and the combination Arnica Montana and Bromelain.
Inclusion Criteria:
-adults scheduled for outpatient primary rhinoplasty with osteotomies at Boston Medical
Center
Exclusion Criteria:
- oral or contact allergies to Arnica Montana or to derivatives from the Ananas comosus
or to any other member of the Asteraceae family of plants such as ragweed,
chrysanthemums, marigolds, and daisies or Bromelain as determined by self disclosure.
- allergies to pineapple as Bromelain is from pineapple extract
- currently taking antiplatelet medication or anticoagulation medications
- chronic use of NSAIDs meaning those currently using NSAIDS daily for at least 3 months
- taking other homeopathic remedies during the perioperative period
- bleeding disorders as determined by self-disclosure or strong family history, patients
in question who would like to participate in the study will have blood work obtained
prior to operation
- chronic medical conditions such as significant pulmonary, cardiac, liver, or kidney
disease are excluded including poorly controlled hypertension or patients on more than
one antihypertensive agent and patients with diabetes
- malignancy, infection, immunodeficiency, metabolic syndrome, infectious, or
inflammatory gastrointestinal disease
- severe liver or kidney disease
- significant psychiatric disorders
- females who are breast feeding or pregnant
- history of nasal surgery
- history of head and neck malignancy
- taking oral corticosteroid therapy
- undergoing additional surgery other than primary rhinoplasty
We found this trial at
1
site
Click here to add this to my saved trials